NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01364376,"S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric Carcinoma",https://clinicaltrials.gov/study/NCT01364376,Focus,COMPLETED,"This is a randomized multicenter controlled study of oxaliplatin, leucovorin calcium , plus 5-fluorouracil (FOLFOX) compared with S-1 plus oxaliplatin (SOX) as perioperative chemotherapy for advanced gastric cancer.

Hypothesis: SOX is not inferior to FOLFOX as perioperative chemotherapy for advanced gastric cancer.",NO,Stomach Neoplasms,DRUG: S-1; Oxaliplatin; 5-Fu; Leucovorin Calcium,"overall survival, 3-year","progression-free survival(PFS), 3-year|clinical response, 6 or 12 weeks|pathological response, within 10 days after surgery|Number of Participants with grade 3/4 adverse Events, 6 Years",,Zhejiang University,,ALL,"ADULT, OLDER_ADULT",NA,583,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,ZYYY-GC1105,2011-06,2016-08,2016-08,2011-06-02,,2016-08-23,"Qilu Hospital of Shandong University, Jinan, Shandong, China|Shandong Provincial Hospital, Jinan, Shandong, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China|The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, Zhejiang, China|The Second Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, Zhejiang, China|Jiaxing First Hospital, Jiaxing, Zhejiang, China|Ningbo Medical Treatment Center Lihuili Hospital, Ningbo, Zhejiang, China|The second affiliated hospital of Wenzhou medical college, Wenzhou, Zhejiang, China",
